
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunotherapy for nasopharyngeal carcinoma: Current status and prospects (Review)
Huageng Huang, Yuyi Yao, Xinyi Deng, et al.
International Journal of Oncology (2023) Vol. 63, Iss. 2
Open Access | Times Cited: 47
Huageng Huang, Yuyi Yao, Xinyi Deng, et al.
International Journal of Oncology (2023) Vol. 63, Iss. 2
Open Access | Times Cited: 47
Showing 1-25 of 47 citing articles:
Epstein-Barr virus-infected nasopharyngeal carcinoma therapeutics: oncoprotein targets and clinical implications
Jacqueline Kar Kei Mark, Aik-Hong Teh, Beow Keat Yap
Medical Oncology (2025) Vol. 42, Iss. 3
Closed Access | Times Cited: 1
Jacqueline Kar Kei Mark, Aik-Hong Teh, Beow Keat Yap
Medical Oncology (2025) Vol. 42, Iss. 3
Closed Access | Times Cited: 1
High-dose radiation induces dendritic cells maturation by promoting immunogenic cell death in nasopharyngeal carcinoma
Xianlin Zeng, Xin Jin, Junhong Leng, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Xianlin Zeng, Xin Jin, Junhong Leng, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
The Role of Natural Killer Cells in the Tumor Immune Microenvironment of EBV-Associated Nasopharyngeal Carcinoma
Shuzhan Li, Wei Dai, Ngar‐Woon Kam, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1312-1312
Open Access | Times Cited: 5
Shuzhan Li, Wei Dai, Ngar‐Woon Kam, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1312-1312
Open Access | Times Cited: 5
Global, Regional, and National Epidemiology of nasopharyngeal carcinoma in middle-aged and elderly patients from 1990 to 2021
Qiqi Liu, Hanyu Wang, Ze Chen, et al.
Ageing Research Reviews (2024), pp. 102613-102613
Closed Access | Times Cited: 5
Qiqi Liu, Hanyu Wang, Ze Chen, et al.
Ageing Research Reviews (2024), pp. 102613-102613
Closed Access | Times Cited: 5
Berberine-mediated Ferroptosis through System Xc-/GSH/GPX4 Axis Inhibits Metastasis of Nasopharyngeal Carcinoma
Wu Yao, Qunying Jia, Qi Tang, et al.
Journal of Cancer (2023) Vol. 15, Iss. 3, pp. 685-698
Open Access | Times Cited: 12
Wu Yao, Qunying Jia, Qi Tang, et al.
Journal of Cancer (2023) Vol. 15, Iss. 3, pp. 685-698
Open Access | Times Cited: 12
Food and Drug Administration (FDA) Approvals of Biological Drugs in 2023
Alexander C. Martins, Mariana Y. Oshiro, Fernando Alberício, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 1992-1992
Open Access | Times Cited: 4
Alexander C. Martins, Mariana Y. Oshiro, Fernando Alberício, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 1992-1992
Open Access | Times Cited: 4
Immune-related adverse events as prognostic biomarkers in recurrent or metastatic nasopharyngeal carcinoma receiving PD-L1 inhibitor: A post-hoc analysis of the multicenter, single-arm, phase 2 study
Shihong Xu, Jiagang He, Zheran Liu, et al.
Oral Oncology (2025) Vol. 161, pp. 107161-107161
Closed Access
Shihong Xu, Jiagang He, Zheran Liu, et al.
Oral Oncology (2025) Vol. 161, pp. 107161-107161
Closed Access
PLUNC downregulates the expression of PD-L1 by inhibiting the interaction of DDX17/β-catenin in nasopharyngeal carcinoma
Ran-Ran Feng, Yilin Guo, Meilin Chen, et al.
Journal of Pathology and Translational Medicine (2025) Vol. 59, Iss. 1, pp. 68-83
Open Access
Ran-Ran Feng, Yilin Guo, Meilin Chen, et al.
Journal of Pathology and Translational Medicine (2025) Vol. 59, Iss. 1, pp. 68-83
Open Access
Genistein and chlorin E6-loaded versatile nanoformulation for remodeling the hypoxia-related tumor microenvironment and boosting photodynamic therapy in nasopharyngeal carcinoma treatment
Qiang Zhou, Quazi T.H. Shubhra, Peng Lai, et al.
Advanced Composites and Hybrid Materials (2025) Vol. 8, Iss. 1
Closed Access
Qiang Zhou, Quazi T.H. Shubhra, Peng Lai, et al.
Advanced Composites and Hybrid Materials (2025) Vol. 8, Iss. 1
Closed Access
Carboxylesterase 4A Inhibits the Malignant Biological Behavior of Nasopharyngeal Carcinoma via the PI3K/AKT Pathway
Qiaoli Chen, Qian Hao, Yanping Yang, et al.
Technology in Cancer Research & Treatment (2025) Vol. 24
Open Access
Qiaoli Chen, Qian Hao, Yanping Yang, et al.
Technology in Cancer Research & Treatment (2025) Vol. 24
Open Access
Alisol A Inhibited Nasopharyngeal Carcinoma Cells by Inhibiting the Hippo Signaling Pathway
会清 刘
Advances in Clinical Medicine (2025) Vol. 15, Iss. 01, pp. 2243-2249
Closed Access
会清 刘
Advances in Clinical Medicine (2025) Vol. 15, Iss. 01, pp. 2243-2249
Closed Access
The impact of the ATP-binding cassette (ABC) transporter family on multidrug resistance in head and neck tumors
Wei Zhang, Zhengxin Zhu, Yuehui Liu
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Wei Zhang, Zhengxin Zhu, Yuehui Liu
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
The role of SOX18 in nasopharyngeal carcinoma: implications for prognosis and therapy
Gabris Ni, Wenbin Wang, Yuan Dang, et al.
American Journal of Translational Research (2025) Vol. 17, Iss. 2, pp. 913-926
Closed Access
Gabris Ni, Wenbin Wang, Yuan Dang, et al.
American Journal of Translational Research (2025) Vol. 17, Iss. 2, pp. 913-926
Closed Access
Diagnosis of nasopharyngeal disease during upper GI endoscopy
Wei Xie, Qian Yin, Hong Fang, et al.
Gut (2025), pp. gutjnl-334528
Closed Access
Wei Xie, Qian Yin, Hong Fang, et al.
Gut (2025), pp. gutjnl-334528
Closed Access
Induction Camrelizumab and Modified TPF (Nab‐Paclitaxel, Cisplatin, and S‐1) in Locoregionally Advanced Nasopharyngeal Carcinoma
Yifeng Yu, Yaqing Dai, Zongkai Zhang, et al.
Cancer Science (2025)
Open Access
Yifeng Yu, Yaqing Dai, Zongkai Zhang, et al.
Cancer Science (2025)
Open Access
Astragaloside IV inhibits nasopharyngeal carcinoma progression by suppressing the SATB2/Wnt signaling axis
Yinping Zeng, Tingting Duan, Jiajun Huang, et al.
Toxicology Research (2025) Vol. 14, Iss. 2
Open Access
Yinping Zeng, Tingting Duan, Jiajun Huang, et al.
Toxicology Research (2025) Vol. 14, Iss. 2
Open Access
The Immunoradiotherapy in Nasopharyngeal Carcinoma
Jingjing Miao, Caifei Xiang, Chia‐Jyi Liu
(2025), pp. 123-157
Closed Access
Jingjing Miao, Caifei Xiang, Chia‐Jyi Liu
(2025), pp. 123-157
Closed Access
Nasopharyngeal cancer screening and immunotherapy efficacy evaluation based on plasma separation combined with label-free SERS technology
Ruiying Lin, Zhengjin Jiang, Jinyong Lin, et al.
Analytica Chimica Acta (2025), pp. 344070-344070
Closed Access
Ruiying Lin, Zhengjin Jiang, Jinyong Lin, et al.
Analytica Chimica Acta (2025), pp. 344070-344070
Closed Access
PTEN as a prognostic factor for radiotherapy plus immunotherapy response in nasopharyngeal carcinoma
Jiaxing Guo, Ming Zhang, Xiaoli Li, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Jiaxing Guo, Ming Zhang, Xiaoli Li, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Integrative analysis of taurine metabolism-related genes prognostic signature with immunotherapy and identification of ABCB1 and GORASP1 as key genes in nasopharyngeal carcinoma
Feng Zhang, Yuhang Yang, Wenqi Luo, et al.
Amino Acids (2025) Vol. 57, Iss. 1
Open Access
Feng Zhang, Yuhang Yang, Wenqi Luo, et al.
Amino Acids (2025) Vol. 57, Iss. 1
Open Access
Deubiquitinating enzyme UCHL1 stabilizes CAV1 to inhibit ferroptosis and enhance docetaxel resistance in nasopharyngeal carcinoma
Yixian Ye, Peng Wang, Daquan Wu, et al.
Anti-Cancer Drugs (2025)
Closed Access
Yixian Ye, Peng Wang, Daquan Wu, et al.
Anti-Cancer Drugs (2025)
Closed Access
Sesamin Exerts Anti-Tumor Activity in Nasopharyngeal Carcinoma Through Inducing Autophagy and Reactive Oxygen Species Production
Deqiang An, Xianyao Jiang, Yang Yucheng
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 4
Open Access
Deqiang An, Xianyao Jiang, Yang Yucheng
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 4
Open Access
Additional PD-1 inhibitor improves complete response to induction chemotherapy in locally advanced nasopharyngeal carcinoma
Yi‐Feng Yu, Guanzhong Lu, Runjie Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Yi‐Feng Yu, Guanzhong Lu, Runjie Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
EBV-positive glycoproteins associated with nasopharyngeal carcinoma
Chenlu Zeng, Muchuan Qiao, Yanhua Chen, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155427-155427
Closed Access | Times Cited: 2
Chenlu Zeng, Muchuan Qiao, Yanhua Chen, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155427-155427
Closed Access | Times Cited: 2
Global epidemiological profile in nasopharyngeal carcinoma: a prediction study
Yuna Zhang, Shanshan Gu, Hongxia Deng, et al.
BMJ Open (2024) Vol. 14, Iss. 12, pp. e091087-e091087
Open Access | Times Cited: 2
Yuna Zhang, Shanshan Gu, Hongxia Deng, et al.
BMJ Open (2024) Vol. 14, Iss. 12, pp. e091087-e091087
Open Access | Times Cited: 2